SomaLogic, Inc.

SomaLogic, Inc. (Nasdaq: SLGC) is a proteomics technology company that completed its public market debut through a merger with CM Life Sciences III Inc., a special purpose acquisition company sponsored by CM Life Sciences III Sponsor, LLC, an entity affiliated with Casdin Capital and Moore Strategic Ventures. The SPAC conducted its IPO in 2021 and targeted the life sciences and healthcare technology sector. SomaLogic, headquartered in Boulder, Colorado, develops and commercializes its SOMAscan proteomics platform, which enables large-scale protein measurement for biomarker discovery and diagnostics applications. The 8-K filed March 29, 2021 relates to the business combination agreement disclosed during that period. Sign up at SpacDesk for full filing history, sponsor profiles, and real-time SPAC data on SLGC and thousands of other transactions.